This commissioned, peer-reviewed commentary narrates the surgical timeline: perineal prostatectomy (Young, 1905), retropubic (Millin, 1945), anatomic refinements (Reiner & Walsh, 1979), laparoscopy (1990s), and robotic-assisted laparoscopic prostatectomy (RALP) since 2000, which accounted for ~85% of US prostatectomies by 2013 .
Its evidentiary core is the Nahas et al. RCT (n=327; RRP 156, RALP 171): longer operative time with RALP (212 vs 120 min), less blood loss (220 vs 719 mL), faster continence (80.5% vs 64.7% at 3 months), higher potency (30.6% vs 6.9% at 6 months), and similar 36-month oncologic outcomes (20.5% vs 29.2% requiring additional treatment, P=0.069) . This aligns with earlier trials showing similar function at 24 months and 8-year LAPPRO follow-up favoring robotic continence without oncologic compromise .
The editorial is honest about its central caveat: the RCT involved experienced open and robotic surgeons, so results may not generalize to future trainees with declining open exposure . Blind spots it does not fully address: surgeon-experience confounding (which learning-curve data suggest dominates outcomes ), absence of cost-effectiveness discussion, and a large disclosed consulting-fee disclosure list for one authorβrelevant given the technology-favoring narrative. Meta-analytic evidence broadly corroborates lower blood loss and shorter stays with RALP .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.